PCL compounds, compositions, and methods of use thereof
Disclosed herein are compounds useful for detecting oxidants in a living cell, in a multicellular organism, or in a cell-free sample. In particular, disclosed herein are bioluminescent reporter compounds, and more particularly, fluorinated peroxy-caged-luciferin (PCL) compounds, compositions comprising such compounds, methods of using such compounds and compositions, and processes for preparing such compounds. Also disclosed herein are kits and methods for detecting and measuring peroxynitrite, and optionally, additional oxidants in a living cell, in a multicellular organism, or in a cell-free sample.
1. A compound of formula (I),
or a pharmaceutically acceptable salt, ester, amide, prodrug, or radiolabeled form thereof,
wherein R 1 and R 2 are each independently hydroxy or alkoxy, or R 1 and R 2 form together with the boron atom to which they are attached an optionally substituted 5- to 7-membered dioxaborolanyl group; and
wherein * designates a stereocenter.
2. The compound of claim 1 , wherein
R 1 is hydroxy; and
R 2 is hydroxy.
3. The compound of claim 1 , wherein
R 1 is alkoxy; and
R 2 is alkoxy.
4. The compound of claim 1 , wherein R 1 and R 2 form together with the boron atom to which they are attached an optionally substituted 5- to 7-membered dioxaborolanyl group.
5. The compound of claim 4 , wherein R 1 and R 2 form together with the boron atom to which they are attached a 4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl group.
6. The compound of claim 1 wherein * designates a stereocenter having the (S)-configuration.
7. The compound of claim 1 wherein * designates a stereocenter having the (R)-configuration.
8. The compound of claim 1 , having formula (I-A),
9. The compound of claim 1 , having formula (I-B)
10. A method of detecting one or more oxidants in a cell or tissue comprising:
(a) contacting the cell or tissue with an effective amount of one or more compounds of formula (I):
or a pharmaceutically acceptable salt, ester, amide, prodrug, or radiolabeled form thereof,
wherein R 1 and R 2 are each independently hydroxy or alkoxy, or R 1 and R 2 form together with the boron atom to which they are attached an optionally substituted 5- to 7-membered dioxaborolanyl group, and
wherein * designates a stereocenter; and
(b) detecting a signal generated by reaction of the one or more compounds of formula (I) with the one or more oxidants.
11. The method of claim 10 , wherein the one or more compounds of formula (I) comprise formula (I-A),
12. The method of claim 10 , wherein the one or more compounds of formula (I) comprise PCL-F:
the method further comprising contacting the cell or tissue with an effective amount of PCL-1:
and detecting a signal generated by reaction of PCL-1 with the one or more oxidants.
13. The method of claim 10 , wherein the one or more oxidants comprise peroxynitrite.
14. The method of claim 10 , wherein the one or more oxidants comprise hydrogen peroxide.
15. The method of claim 10 , wherein the one or more oxidants comprise peroxynitrite and hydrogen peroxide.
16. The method of claim 10 ,
wherein the one or more compounds of formula (I) comprise PCL-F:
the method further comprising contacting the cell or tissue with an effective amount of coumarin-7-boronic acid (CBA) and detecting a signal generated by reaction of CBA with the one or more oxidants.
17. A method of detecting radiation-induced gastrointestinal injury in a subject comprising:
(a) administering to the subject one or more compounds according to claim 1 ; and
(b) detecting a signal generated by reaction of the one or more compounds according to claim 1 with peroxynitrite in the feces of the subject.
18. A method of detecting radiation-induced gastrointestinal injury in a subject comprising:
(a) administering to the subject PCL-1:
and
(b) detecting a signal generated by reaction of PCL-1 with peroxynitrite in the feces of the subject.